Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride

References

• Smith MJ, Kong M, Cambon A, Woods CR. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. Pediatrics 2012;129:e1326–33
   PubMed Web of Science ®Google Scholar
• Frei CR, Attridge RT, Mortensen EM, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 2010;32:293–9
   PubMed Web of Science ®Google Scholar
• Larsson P, Brandsborg E, Forsum U, et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis 2011;11:223–37
   PubMed Web of Science ®Google Scholar
• James KA, Burkhart CN, Morell DS. Emerging drugs for acne. Expert Opin Emerging Drugs 2009;14:649–59
   PubMed Web of Science ®Google Scholar
• The Merck Index, 14th ed, v. 14.9, 2012. Available from: http://www.knovel.com [last accessed 1 Sept 2012]
   Google Scholar
• Lindgren S, Janzon L. Dysphagia: prevalence of swallowing complaints and clinical finding. Med Clin North Am 1993;77:3–5
   Google Scholar
• Mazur E, Schug BS, Evers G, et al. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation. Int J Clin Pharm Ther 1999;37:386–92
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (US). Guidance for industry: orally disintegrating tablets. 2008. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070578.pdf [last accessed 12 April 2013]
   Google Scholar
• Tokuyama E, Matsunaga C, Yoshida K, et al. Famotidine orally disintegrating tablets: bitterness comparison of original and generic products. Chem Pharm Bull 2009;57:382–7
   PubMed Web of Science ®Google Scholar
• Yan Y-D, Woo JS, Kang JH, et al. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull 2010;33:1364–70
   PubMed Web of Science ®Google Scholar
• Ibrahim HK, El-Setouhy DA. Valsartan orodispersible tablets: formulation, in vitro/in vivo characterization. AAPS PharmSciTech 2010;11:189–96
   PubMed Web of Science ®Google Scholar
• Sheshala R, Khan N, Darwis Y. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate. Chem Pharm Bull 2011;59:920–8
   PubMed Web of Science ®Google Scholar
• Douroumis D. Orally disintegrating dosage forms and taste-masking technologies. Expert Opin Drug Deliv 2011;8:665–75
   PubMed Web of Science ®Google Scholar
• Bodmeier R. Tabletting of coated pellets. Eur J Pharm Biopharm 1997;43:1–8
   Web of Science ®Google Scholar
• Lin X, Chyi CW, Ruan KF, et al. Development of potential novel cushioning agents for the compaction of coated multi-particulates by co-processing micronized lactose with polymers. Eur J Pharm Biopharm 2011;79:406–15
   PubMed Web of Science ®Google Scholar
• Cantor SL, Hoag SW, Augsburger LL. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs – Part 1 Acetaminophen. Drug Dev Ind Pharm 2009;35:337–51
   PubMed Web of Science ®Google Scholar
• Cantor SL, Hoag SW, Augsburger LL. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs – theophylline & cimetidine. Drug Dev Ind Pharm 2009;35:568–82
   PubMed Web of Science ®Google Scholar
• Cantor SL, Hoag SW, Ellison CD, et al. NIR spectroscopy applications in the development of a compacted multiparticulate system for modified release. AAPS PharmSciTech 2011;12:262–78
   PubMed Web of Science ®Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech 2007;8:e127–33
   Web of Science ®Google Scholar
• Kayumba PC, Huyghebaert N, Cordella C. Quinine sulphate pellets for flexible pediatric drug dosing: formulation development and evaluation of taste-masking efficiency using the electronic tongue. Eur J Pharm Biopharm 2007;66:460–5
   PubMed Web of Science ®Google Scholar
• Xu J, Bovet LL, Zhao K. Taste masking microspheres for orally disintegrating tablets. Int J Pharm 2008;359:63–9
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeial Convention. The United States Pharmacopeia: USP 35: the National Formulary: NF30. Rockville (MD): United States Pharmacopeial Convention; 2012
   Google Scholar
• Aframian DJ, Davidowitz T, Benoliel R. The distribution of oral mucosal pH values in healthy saliva secretors. Oral Dis 2006;12:420–23
   PubMed Web of Science ®Google Scholar
• Coleman NJ, Craig DQM. Modulated temperature differential scanning calorimetry: a novel approach to pharmaceutical thermal analysis. Int J Pharm 1996;135:13–29
   Web of Science ®Google Scholar
• Felton LA, McGinity JW. Adhesion of polymeric films to pharmaceutical solids. Eur J Pharm Biopharm 1999;47:1–14
   PubMed Web of Science ®Google Scholar
• Stanley P, Rowe RC, Newton JM. Theoretical considerations of the influence of polymer film coatings on the mechanical strength of tablets. J Pharm Pharmacol 1981;33:557–60
   PubMed Web of Science ®Google Scholar
• Schmid S, Müller-Goymann CC. Interactions during aqueous film coating of ibuprofen with Aquacoat ECD. Int J Pharm 2000;197:35–9
   PubMed Web of Science ®Google Scholar
• Evonik Industries. Taste masking and moisture protection have never been easier. Available from: http://eudragit.evonik.com/product/eudragit/Documents/evonik-brochure-readymix.pdf [last accessed 12 April 2013]
   Google Scholar
• Evonik Industries. Taste masking formulations: formulation basics for taste masking formulations. Available from: https://e-lab.eudragit.com/application_guidelines/wiki/?v=43 [last accessed 12 April 2013]
   Google Scholar
• Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech 2005;6:e120–6
   PubMed Web of Science ®Google Scholar
• Camarco W, Ray D, Druffner A. Selecting superdisintegrants for orally disintegrating tablet formulations. Pharm Tech 2006;30:S1–5
   Google Scholar
• Mehta S, De Beer T, Remon JP, Vervaet C. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules. Int J Pharm 2012;422:310–17
   PubMed Web of Science ®Google Scholar
• Beckert TE, Lehmann K, Schmidt PC. Compression of enteric-coated pellets to disintegrating tablets: uniformity of dosage units. Powder Technol 1998;96:248–54
   Web of Science ®Google Scholar
• Bendas ER, Christensen JM, Ayres JW. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets. Drug Dev Ind Pharm 1998;36:393–404
   Web of Science ®Google Scholar
• Vergote GJ, Kiekens F, Vervaet C, Remon JP. Wax beads as cushioning agents during the compression of coated diltiazem pellets. Eur J Pharm Sci 2002;17:145–51
   PubMed Web of Science ®Google Scholar